.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
India's leading private healthcare providers are currently reevaluating their involvement in government health schemes India. Hospitals like Max Healthcare and Narayana Health report significant revenue pressure. Consequently, experts suggest a shift toward more sustainable payer mixes. This trend reflects growing frustration over pricing curbs and payment delays. Furthermore, the share of revenue from these programs is expected to decline by 2027.
Industry data indicates that schemes like CGHS and ECHS account for roughly 25% of revenue at top facilities. However, low reimbursement rates often force hospitals to sell services below cost. For instance, Max Healthcare reported a Rs 200-crore impact from chemotherapy drug discounts. Moreover, hospitals are now capping bed allocations for these patients. These strategic moves aim to protect working capital and ensure long-term viability. As a result, many groups are leaning on private patients and insurance categories to bolster their earnings.
Many leading healthcare groups are now moving toward payers with shorter collection periods. Consequently, this shift helps maintain healthier working capital during economic uncertainty. Furthermore, some facilities have started pledging government receivables as collateral for short-term loans. This situation highlights the urgent need for rate revisions to sustain public-private partnerships. Although some revisions occurred recently, the full financial impact remains uncertain. Experts believe that without structural changes, the participation of top-tier hospitals will continue to dwindle.
Q1: Which schemes are primarily affected by these hospital decisions?
The Central Government Health Scheme (CGHS) and the Ex-Servicemen Contributory Health Scheme (ECHS) are the primary programs facing participation challenges due to low rates.
Q2: How are hospitals managing the financial losses from these schemes?
Hospitals are managing losses by capping bed allocations for scheme patients and focusing on high-value treatments for private and insured patients.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Major private hospitals in India are scaling back government health scheme participation due to low rates and payment delays affecting financial sustainabil...
4 months ago
A large NHANES cohort study reveals that higher Healthy Eating Index scores significantly reduce all-cause mortality risk in CKD patients by 45%. This analysis highlights the importance of comprehensive diet quality and medical nutrition therapy in renal care to optimize long-term clinical survival.
Today
Explore real-world data showing how private oncogenetics and molecular tumor boards achieve 3-week consult turnaround, high ctDNA actionability, and vital germline variant detection, enhancing individualized cancer care and familial risk assessment.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Today
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
